Novel AlkB dioxygenases--alternative models for in silico and in vivo studies.

<h4>Background</h4>ALKBH proteins, the homologs of Escherichia coli AlkB dioxygenase, constitute a direct, single-protein repair system, protecting cellular DNA and RNA against the cytotoxic and mutagenic activity of alkylating agents, chemicals significantly contributing to tumor format...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Damian Mielecki, Dorota Ł Zugaj, Anna Muszewska, Jan Piwowarski, Aleksandra Chojnacka, Marcin Mielecki, Jadwiga Nieminuszczy, Marcin Grynberg, Elżbieta Grzesiuk
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/e753042fc77542ea8e75a36a18874a4c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e753042fc77542ea8e75a36a18874a4c
record_format dspace
spelling oai:doaj.org-article:e753042fc77542ea8e75a36a18874a4c2021-11-18T07:29:27ZNovel AlkB dioxygenases--alternative models for in silico and in vivo studies.1932-620310.1371/journal.pone.0030588https://doaj.org/article/e753042fc77542ea8e75a36a18874a4c2012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22291995/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>ALKBH proteins, the homologs of Escherichia coli AlkB dioxygenase, constitute a direct, single-protein repair system, protecting cellular DNA and RNA against the cytotoxic and mutagenic activity of alkylating agents, chemicals significantly contributing to tumor formation and used in cancer therapy. In silico analysis and in vivo studies have shown the existence of AlkB homologs in almost all organisms. Nine AlkB homologs (ALKBH1-8 and FTO) have been identified in humans. High ALKBH levels have been found to encourage tumor development, questioning the use of alkylating agents in chemotherapy. The aim of this work was to assign biological significance to multiple AlkB homologs by characterizing their activity in the repair of nucleic acids in prokaryotes and their subcellular localization in eukaryotes.<h4>Methodology and findings</h4>Bioinformatic analysis of protein sequence databases identified 1943 AlkB sequences with eight new AlkB subfamilies. Since Cyanobacteria and Arabidopsis thaliana contain multiple AlkB homologs, they were selected as model organisms for in vivo research. Using E. coli alkB(-) mutant and plasmids expressing cyanobacterial AlkBs, we studied the repair of methyl methanesulfonate (MMS) and chloroacetaldehyde (CAA) induced lesions in ssDNA, ssRNA, and genomic DNA. On the basis of GFP fusions, we investigated the subcellular localization of ALKBHs in A. thaliana and established its mostly nucleo-cytoplasmic distribution. Some of the ALKBH proteins were found to change their localization upon MMS treatment.<h4>Conclusions</h4>Our in vivo studies showed highly specific activity of cyanobacterial AlkB proteins towards lesions and nucleic acid type. Subcellular localization and translocation of ALKBHs in A. thaliana indicates a possible role for these proteins in the repair of alkyl lesions. We hypothesize that the multiplicity of ALKBHs is due to their involvement in the metabolism of nucleo-protein complexes; we find their repair by ALKBH proteins to be economical and effective alternative to degradation and de novo synthesis.Damian MieleckiDorota Ł ZugajAnna MuszewskaJan PiwowarskiAleksandra ChojnackaMarcin MieleckiJadwiga NieminuszczyMarcin GrynbergElżbieta GrzesiukPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 1, p e30588 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Damian Mielecki
Dorota Ł Zugaj
Anna Muszewska
Jan Piwowarski
Aleksandra Chojnacka
Marcin Mielecki
Jadwiga Nieminuszczy
Marcin Grynberg
Elżbieta Grzesiuk
Novel AlkB dioxygenases--alternative models for in silico and in vivo studies.
description <h4>Background</h4>ALKBH proteins, the homologs of Escherichia coli AlkB dioxygenase, constitute a direct, single-protein repair system, protecting cellular DNA and RNA against the cytotoxic and mutagenic activity of alkylating agents, chemicals significantly contributing to tumor formation and used in cancer therapy. In silico analysis and in vivo studies have shown the existence of AlkB homologs in almost all organisms. Nine AlkB homologs (ALKBH1-8 and FTO) have been identified in humans. High ALKBH levels have been found to encourage tumor development, questioning the use of alkylating agents in chemotherapy. The aim of this work was to assign biological significance to multiple AlkB homologs by characterizing their activity in the repair of nucleic acids in prokaryotes and their subcellular localization in eukaryotes.<h4>Methodology and findings</h4>Bioinformatic analysis of protein sequence databases identified 1943 AlkB sequences with eight new AlkB subfamilies. Since Cyanobacteria and Arabidopsis thaliana contain multiple AlkB homologs, they were selected as model organisms for in vivo research. Using E. coli alkB(-) mutant and plasmids expressing cyanobacterial AlkBs, we studied the repair of methyl methanesulfonate (MMS) and chloroacetaldehyde (CAA) induced lesions in ssDNA, ssRNA, and genomic DNA. On the basis of GFP fusions, we investigated the subcellular localization of ALKBHs in A. thaliana and established its mostly nucleo-cytoplasmic distribution. Some of the ALKBH proteins were found to change their localization upon MMS treatment.<h4>Conclusions</h4>Our in vivo studies showed highly specific activity of cyanobacterial AlkB proteins towards lesions and nucleic acid type. Subcellular localization and translocation of ALKBHs in A. thaliana indicates a possible role for these proteins in the repair of alkyl lesions. We hypothesize that the multiplicity of ALKBHs is due to their involvement in the metabolism of nucleo-protein complexes; we find their repair by ALKBH proteins to be economical and effective alternative to degradation and de novo synthesis.
format article
author Damian Mielecki
Dorota Ł Zugaj
Anna Muszewska
Jan Piwowarski
Aleksandra Chojnacka
Marcin Mielecki
Jadwiga Nieminuszczy
Marcin Grynberg
Elżbieta Grzesiuk
author_facet Damian Mielecki
Dorota Ł Zugaj
Anna Muszewska
Jan Piwowarski
Aleksandra Chojnacka
Marcin Mielecki
Jadwiga Nieminuszczy
Marcin Grynberg
Elżbieta Grzesiuk
author_sort Damian Mielecki
title Novel AlkB dioxygenases--alternative models for in silico and in vivo studies.
title_short Novel AlkB dioxygenases--alternative models for in silico and in vivo studies.
title_full Novel AlkB dioxygenases--alternative models for in silico and in vivo studies.
title_fullStr Novel AlkB dioxygenases--alternative models for in silico and in vivo studies.
title_full_unstemmed Novel AlkB dioxygenases--alternative models for in silico and in vivo studies.
title_sort novel alkb dioxygenases--alternative models for in silico and in vivo studies.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/e753042fc77542ea8e75a36a18874a4c
work_keys_str_mv AT damianmielecki novelalkbdioxygenasesalternativemodelsforinsilicoandinvivostudies
AT dorotałzugaj novelalkbdioxygenasesalternativemodelsforinsilicoandinvivostudies
AT annamuszewska novelalkbdioxygenasesalternativemodelsforinsilicoandinvivostudies
AT janpiwowarski novelalkbdioxygenasesalternativemodelsforinsilicoandinvivostudies
AT aleksandrachojnacka novelalkbdioxygenasesalternativemodelsforinsilicoandinvivostudies
AT marcinmielecki novelalkbdioxygenasesalternativemodelsforinsilicoandinvivostudies
AT jadwiganieminuszczy novelalkbdioxygenasesalternativemodelsforinsilicoandinvivostudies
AT marcingrynberg novelalkbdioxygenasesalternativemodelsforinsilicoandinvivostudies
AT elzbietagrzesiuk novelalkbdioxygenasesalternativemodelsforinsilicoandinvivostudies
_version_ 1718423383537876992